About this Session:
Have we entered a new era of drug development with shorter timelines, lower costs and more advanced treatments coming to market? The COVID vaccines certainly proved this theory to be true, but how will this urgency translate post-pandemic? Through increased use of new technologies like mRNA and implementing highly digitized, flexible, data-driven operations, life science leaders are reinventing old R&D methods in new ways. Hear two life science leaders’ unique approaches to R&D reinvention.